HCmed Innovations is a company focused on the development of drug-device combination products for inhalation therapy. It develops and manufactures portable vibrating mesh nebulizers that offer a mature customization platform. This technology enables efficient and reliable nebulization of different types of medication, including small molecule synthetics and large molecule biologics, as either solutions, suspensions, or even difficult-to-deliver high viscosity drugs. The newest products include the incorporation of breath actuation and connectivity features to enhance drug delivery and reinforce patience adherence.
投資雷達 查看更多
- 法人一周動態:12/04-12/08(買超)高端疫苗3095.2張、台耀1871.06張、太景*-KY1644.44張;(賣超)松瑞藥2167.75張、美時1995.79張、合一1491.84張
- 台股一周TOP 15:12/04-12/08(漲)全宇生技-KY11.32%、福永生技8.91%、聿新科4.3%
- 2023-12-08生技股:(漲)福永生技10%、皇將4.8%、永日4.05%;(跌)軒郁7.89%、合世3.68%、達爾膚2.93%
- 2023-12-08法人動態:(買超)永日488張、高端疫苗213張、大樹179張;(賣超)晶碩1341張、軒郁620張、台耀397張
- 2023-12-07生技股:(漲)加捷生醫4.76%、全宇生技-KY3.25%、順藥3%;(跌)皇將9.86%、永日7.38%、合世5.61%